Frontiers in Cardiovascular Medicine
JULY 24, 2024
This review delves into the current therapeutic strategies for CTEPH, including surgical pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), and targeted pharmacological treatments such as PDE5 inhibitors, endothelin receptor antagonists, sGC stimulators, and prostanoids.
Dr. Smith's ECG Blog
FEBRUARY 8, 2015
The supposition that beta blockade in the presence of cocaine intoxication would lead to unopposed alpha constriction is not based in accurate pharmacology, and the study that showed this effect with human intracoronary administration was done, as mentioned in the article, with propranolol, a nonselective beta blocker.
Cardiology Update
JANUARY 7, 2024
Fellows 2024 offers hands-on training covering revascularization, angioplasty, stents, pharmacologic therapy, and intravascular imaging/physiology. Noncoronary topics like structural heart disease and vascular medicine are also addressed. Ample networking opportunities with faculty are provided.
DAIC
FEBRUARY 29, 2024
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Journal of Cardiovascular Pharmacology
DECEMBER 11, 2023
Nevertheless, the function and underlying mechanism of MALAT1 in restenosis induced by hypertensive angioplasty remain unclear. Nevertheless, the function and underlying mechanism of MALAT1 in restenosis induced by hypertensive angioplasty remain unclear. AngII increased the expression of MALAT1 in VSMCs.
Expert insights. Personalized for you.
98 
Let's personalize your content